These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 23708661)

  • 21. Identification of aberrant cell cycle regulation in Epstein-Barr virus-associated nasopharyngeal carcinoma by cDNA microarray and gene set enrichment analysis.
    Zhang W; Zeng Z; Zhou Y; Xiong W; Fan S; Xiao L; Huang D; Li Z; Li D; Wu M; Li X; Shen S; Wang R; Cao L; Tang K; Li G
    Acta Biochim Biophys Sin (Shanghai); 2009 May; 41(5):414-28. PubMed ID: 19430707
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MicroRNA‑19b inhibitors can attenuate the STAT3 signaling pathway in NPC C666‑1 cells.
    Bian LH; Duan JL; Zhou C; Shen GW; Wang XY; Yang Y; Zhang XL; Xiao SJ
    Mol Med Rep; 2020 Jul; 22(1):51-56. PubMed ID: 32377721
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhanced therapeutic efficacy of adenovirus-mediated interleukin-24 gene therapy combined with ionizing radiotherapy for nasopharyngeal carcinoma.
    Liu J; Zhang Y; Sun P; Xie Y; Xiang J; Yang J
    Oncol Rep; 2013 Sep; 30(3):1165-74. PubMed ID: 23783436
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stat3 inhibitor Stattic exhibits potent antitumor activity and induces chemo- and radio-sensitivity in nasopharyngeal carcinoma.
    Pan Y; Zhou F; Zhang R; Claret FX
    PLoS One; 2013; 8(1):e54565. PubMed ID: 23382914
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acylglycerol kinase promotes paclitaxel resistance in nasopharyngeal carcinoma cells by regulating FOXM1 via the JAK2/STAT3 pathway.
    Zhao C; Chen HY; Zhao F; Feng HJ; Su JP
    Cytokine; 2021 Dec; 148():155595. PubMed ID: 34116927
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Opa interacting protein 5 promotes metastasis of nasopharyngeal carcinoma cells by promoting EMT via modulation of JAK2/STAT3 signal.
    Zheng YQ; Cui YR; Yang S; Wang YP; Qiu YJ; Hu WL
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):613-621. PubMed ID: 30720169
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ABT-199-mediated inhibition of Bcl-2 as a potential therapeutic strategy for nasopharyngeal carcinoma.
    Wang Y; Wang Y; Fan X; Song J; Wu H; Han J; Lu L; Weng X; Nie G
    Biochem Biophys Res Commun; 2018 Sep; 503(3):1214-1220. PubMed ID: 30017199
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nitidine chloride inhibits hepatocellular carcinoma cell growth in vivo through the suppression of the JAK1/STAT3 signaling pathway.
    Liao J; Xu T; Zheng JX; Lin JM; Cai QY; Yu DB; Peng J
    Int J Mol Med; 2013 Jul; 32(1):79-84. PubMed ID: 23613111
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reactive nitrogen species-dependent DNA damage in EBV-associated nasopharyngeal carcinoma: the relation to STAT3 activation and EGFR expression.
    Ma N; Kawanishi M; Hiraku Y; Murata M; Huang GW; Huang Y; Luo DZ; Mo WG; Fukui Y; Kawanishi S
    Int J Cancer; 2008 Jun; 122(11):2517-25. PubMed ID: 18307254
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatocyte growth factor suppresses tumor cell apoptosis in nasopharyngeal carcinoma by upregulating Bcl-2 protein expression.
    Li-juan B; Bing L; Zhi L; Yang L; Ying-jie L
    Pathol Res Pract; 2009; 205(12):828-37. PubMed ID: 19625133
    [TBL] [Abstract][Full Text] [Related]  

  • 31. miR-519 suppresses nasopharyngeal carcinoma cell proliferation by targeting oncogene URG4/URGCP.
    Yu G; Zhang T; Jing Y; Bao Q; Tang Q; Zhang Y
    Life Sci; 2017 Apr; 175():47-51. PubMed ID: 28315691
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Induction of metastatic potential by TrkB via activation of IL6/JAK2/STAT3 and PI3K/AKT signaling in breast cancer.
    Kim MS; Lee WS; Jeong J; Kim SJ; Jin W
    Oncotarget; 2015 Nov; 6(37):40158-71. PubMed ID: 26515594
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effects of microRNA-98 inhibits cell proliferation and invasion by targeting STAT3 in nasopharyngeal carcinoma.
    Liu J; Chen W; Chen Z; Wen J; Yu H; Wang F; Wu L; He X
    Biomed Pharmacother; 2017 Sep; 93():869-878. PubMed ID: 28724212
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [
    Fang Y; Wang S; Yang Q; You S; Xing X
    Nan Fang Yi Ke Da Xue Xue Bao; 2022 Jun; 42(6):905-912. PubMed ID: 35790442
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlation of the expressions of IGF1R-RACK1-STAT3 and Bcl-xl in nasopharyngeal carcinoma with the clinicopathological features and prognosis of nasopharyngeal carcinoma.
    Wang S; Shen M; Wen X; Han XR; Wang YJ; Fan SH; Zhuang J; Zhang ZF; Shan Q; Li MQ; Hu B; Sun CH; Ge X; Lei QM; Wu DM; Lu J; Zheng YL
    J Cell Biochem; 2018 Feb; 119(2):1931-1941. PubMed ID: 28816378
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pien Tze Huang suppresses IL-6-inducible STAT3 activation in human colon carcinoma cells through induction of SOCS3.
    Shen A; Chen Y; Hong F; Lin J; Wei L; Hong Z; Sferra TJ; Peng J
    Oncol Rep; 2012 Dec; 28(6):2125-30. PubMed ID: 23027374
    [TBL] [Abstract][Full Text] [Related]  

  • 37. STAT3 activation contributes directly to Epstein-Barr virus-mediated invasiveness of nasopharyngeal cancer cells in vitro.
    Lui VW; Wong EY; Ho Y; Hong B; Wong SC; Tao Q; Choi GC; Au TC; Ho K; Yau DM; Ma BB; Hui EP; Chan AS; Tsang CM; Tsao SW; Grandis JR; Chan AT
    Int J Cancer; 2009 Oct; 125(8):1884-93. PubMed ID: 19588483
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MiR-125b regulates proliferation and apoptosis of nasopharyngeal carcinoma by targeting A20/NF-κB signaling pathway.
    Zheng Z; Qu JQ; Yi HM; Ye X; Huang W; Xiao T; Li JY; Wang YY; Feng J; Zhu JF; Lu SS; Yi H; Xiao ZQ
    Cell Death Dis; 2017 Jun; 8(6):e2855. PubMed ID: 28569771
    [TBL] [Abstract][Full Text] [Related]  

  • 39. LOC401317, a p53-regulated long non-coding RNA, inhibits cell proliferation and induces apoptosis in the nasopharyngeal carcinoma cell line HNE2.
    Gong Z; Zhang S; Zeng Z; Wu H; Yang Q; Xiong F; Shi L; Yang J; Zhang W; Zhou Y; Zeng Y; Li X; Xiang B; Peng S; Zhou M; Li X; Tan M; Li Y; Xiong W; Li G
    PLoS One; 2014; 9(11):e110674. PubMed ID: 25422887
    [TBL] [Abstract][Full Text] [Related]  

  • 40. (-)-Oleocanthal inhibits growth and metastasis by blocking activation of STAT3 in human hepatocellular carcinoma.
    Pei T; Meng Q; Han J; Sun H; Li L; Song R; Sun B; Pan S; Liang D; Liu L
    Oncotarget; 2016 Jul; 7(28):43475-43491. PubMed ID: 27259268
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.